Evidence map›Paper›PMID 30280980›Full record

ArticleJournal of neurotrauma2019

Pharmacological Stimulation of Mitochondrial Biogenesis Using the Food and Drug Administration-Approved β

Natalie E Scholpa, Hannah Williams, Wenxue Wang, Daniel Corum, Aarti Narang, Stephen Tomlinson, Patrick G Sullivan, Alexander G Rabchevsky, Rick G Schnellmann

Abstract read
In one paragraph

Article in Journal of neurotrauma, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 53 citations in OpenAlex.

  1. Norepinephrine regulates hippocampal mitochondrial biogenesis via β2-adrenergic receptor signaling and PGC-1α.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. [Advances of the role of mitochondrial dysfunction in the spinal cord injury and its relevant treatments].Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Natalie E Scholpa1 Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, Arizona.
Hannah Williams3 Department of Physiology, Spinal Cord and Brain Injury Research Center, University of Kentucky Medical Center, Lexington, Kentucky.
Wenxue Wang4 Neuroscience Institute, Medical University of South Carolina, Charleston, South Carolina.
Daniel Corum2 Department of Drug Discovery and Biomedical Sciences, Medical University of South Carolina, Charleston, South Carolina.
Aarti Narang4 Neuroscience Institute, Medical University of South Carolina, Charleston, South Carolina.
Stephen Tomlinson4 Neuroscience Institute, Medical University of South Carolina, Charleston, South Carolina.
Patrick G Sullivan7 Department of Neuroscience, Spinal Cord and Brain Injury Research Center, University of Kentucky Medical Center, Lexington, Kentucky.
Alexander G Rabchevsky3 Department of Physiology, Spinal Cord and Brain Injury Research Center, University of Kentucky Medical Center, Lexington, Kentucky.
Rick G Schnellmann1 Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, Arizona.
Medical University of South Carolina · USUniversity of Kentucky · USUniversity of Arizona · US

Funding

SOUTHWEST ENVIRONMENTAL HEALTH SCIENCES CENTERP30ES006694 · NIEHS · UNIVERSITY OF ARIZONA · PI DEAN BILLHEIMER · 1994 to 2026
$36.7M
Mitochondrial Biogenesis Promotes Recovery From Oxidant InjuryR01GM084147 · NIGMS · UNIVERSITY OF ARIZONA · PI SCHNELLMANN, RICK G · 2008 to 2016
$2.4M
NIEHS NIH HHS P30 ES006694NIGMS NIH HHS R01 GM084147
6 · The paper itself

Abstract

A hallmark of the progressive cascade of damage referred to as secondary spinal cord injury (SCI) is vascular disruption resulting in decreased oxygen delivery and loss of mitochondria homeostasis. While therapeutics targeting restoration of single facets of mitochondrial function have proven largely ineffective clinically post-SCI, comprehensively addressing mitochondrial function via pharmacological stimulation of mitochondrial biogenesis (MB) is an underexplored strategy. This study examined the effects of formoterol, a mitochondrial biogenic Food and Drug Administration-approved selective and potent β

Indexed as

Organelle BiogenesisAdrenergic beta-2 Receptor AgonistsAnimalsFemaleFormoterol FumarateMiceMice, Inbred C57BLMitochondriaRecovery of FunctionSpinal Cord InjuriesAdrenergic beta-2 Receptor AgonistsFormoterol Fumarateformoterolmitochondrial biogenesisrecoveryspinal cord injuryβ-adrenoreceptor

Identifiers

PMID30280980
PMCPMC6484358
OpenAlexW2895731123

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.